Albuterol side effects on heart rate
Pro Research Analysisby 
Searched over 200M research papers
Albuterol and Heart Rate: Cardiovascular Side Effects
Albuterol-Induced Increases in Heart Rate
Albuterol, a commonly used beta2-agonist for asthma and other respiratory conditions, is known to cause increases in heart rate (tachycardia) as a side effect. Studies in both adults and children have shown that inhaled or parenteral albuterol can significantly increase heart rate, with the effect often observed within minutes of administration and peaking within 30 minutes Küng1987Rohr1986. The average increase in heart rate can range from about 6 to 11 beats per minute, depending on the dose and route of administration Rohr1986Kelly2013. High doses of inhaled albuterol are associated with a dose-related increase in heart rate, as well as other side effects such as tremor and changes in blood pressure .
Heart Rate Effects in Different Patient Populations
In critically ill adults and intensive care patients, short-term use of nebulized albuterol generally causes only small, clinically insignificant increases in heart rate, even in those with baseline tachycardia Khorfan2009Lam2003. Similarly, in pediatric cardiology patients, both racemic albuterol and levalbuterol were associated with equivalent, modest increases in heart rate (about 6–7 beats per minute) . In children with asthma, repeated doses of inhaled albuterol did not result in significant arrhythmias or dangerous heart rate changes, suggesting a substantial margin of safety in this population .
Comparison with Levalbuterol and Other Bronchodilators
Levalbuterol, the single-isomer form of albuterol, has been studied as a potentially safer alternative regarding heart rate effects. However, research shows that both albuterol and levalbuterol cause similar increases in heart rate, and the difference between them is not clinically significant in most cases Khorfan2009Lam2003Kelly2013+1 MORE. Substitution of levalbuterol for albuterol solely to avoid tachycardia is generally unwarranted .
High-Dose and Continuous Albuterol Administration
When albuterol is administered in higher doses or by continuous nebulization, there is a dose-related increase in heart rate, but the changes are usually not severe enough to outweigh the benefits of bronchodilation in acute asthma or severe airflow limitation Vathenen1988Lin1993. Continuous or intermittent nebulization at standard doses is considered safe, with no significant chronotropic (heart rate) effects observed in adult emergency department patients .
Albuterol in Special Clinical Situations
In patients with acute cervical spinal cord injury, enteral albuterol was associated with a lower occurrence of bradycardia (slow heart rate) and was well tolerated, with very few episodes of tachycardia or other significant side effects . This suggests that albuterol may be safely used in specific clinical scenarios where heart rate management is important.
Conclusion
Albuterol commonly causes a mild to moderate increase in heart rate, especially at higher doses, but these effects are generally not clinically significant for most patients. The risk of serious arrhythmias or dangerous tachycardia is low, even with repeated or high-dose use, and the heart rate effects are similar between albuterol and levalbuterol. Overall, albuterol remains a safe and effective bronchodilator, with manageable cardiovascular side effects in most patient populations Küng1987Rohr1986Khorfan2009+7 MORE.
Sources and full results
Most relevant research papers on this topic
Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol. Influence of mouth rinsing and gargling.
Mouth rinsing and gargling do not effectively reduce the magnitude of cardiovascular and metabolic side effects associated with increased doses of albuterol.
Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients.
Nebulized albuterol and ipratropium do not cause significant tachycardia or tachyarrhythmias in critically ill adult patients, and substituting levalbuterol for albuterol is unwarranted.
Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients.
Nebulized albuterol and levalbuterol both cause similar short-term increases in heart rate in intensive care patients with or without baseline tachycardia.
DOI